The Misleading Marketing of “Low-T” Drugs A conversation with Adriane Fugh-Berman, MD, Associate Professor at Georgetown University Medical Center and Director of PharmedOut.
Also read this article published on LinkedIn:
Abbvie misleads while AZ, Lilly, GSK engage. All are lobbying energetically!
AbbVie Must Pay $150 Million for Misleading AndroGel Marketing, But Not to DOJ!
